BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 19286758)

  • 1. Impact of renin-angiotensin system polymorphisms on renal haemodynamic responsiveness to acute angiotensin-converting enzyme inhibition in type 2 diabetes mellitus.
    Volkan-Salanci B; Dagdelen S; Alikasifoglu M; Erbas T; Hayran M; Erbas B
    J Renin Angiotensin Aldosterone Syst; 2009 Mar; 10(1):41-50. PubMed ID: 19286758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA; Götz AK; Krüger B; Hösl M; Schmitz G; Riegger GA; Krämer BK
    Eur J Med Res; 2005 Apr; 10(4):161-8. PubMed ID: 15946912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
    Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system gene polymorphisms and premature coronary heart disease.
    Sekuri C; Cam FS; Ercan E; Tengiz I; Sagcan A; Eser E; Berdeli A; Akin M
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):38-42. PubMed ID: 16088850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
    Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
    J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
    Patel TV; Williams GH; Fisher ND
    J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
    Rashtchizadeh N; Aghaeishahsavari M; Argani H; Noroozianavval M; Veisi P; Ghorbanihaghjo A
    Clin Biochem; 2007 Feb; 40(3-4):194-200. PubMed ID: 17222813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
    Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
    Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system polymorphisms and renal graft function in renal transplant recipients.
    Argani H; Noroozianavval M; Aghaeishahsavari M; Veisi P; Rashtchizadeh N; Ghorbanihaghjo A; Bonyadi M; Asgarzadeh M; Hamzeiy H
    Saudi Med J; 2007 Oct; 28(10):1496-502. PubMed ID: 17914507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion/deletion polymorphism of angiotensin I converting enzyme gene and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
    Moleda P; Majkowska L; Kaliszczak R; Safranow K; Adler G; Goracy I
    Kardiol Pol; 2006 Sep; 64(9):959-65; discussion 966. PubMed ID: 17054027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low renin-angiotensin system activity gene polymorphism and dysplasia associated with posterior urethral valves.
    Peruzzi L; Lombardo F; Amore A; Merlini E; Restagno G; Silvestro L; Papalia T; Coppo R
    J Urol; 2005 Aug; 174(2):713-7. PubMed ID: 16006956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
    Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in Type 1 diabetes.
    Komers R; Simkova R; Kazdova L; Ruzickova J; Pelikanova T
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):33-8. PubMed ID: 15136972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between I/D polymorphism of angiotensin I converting enzyme gene and microvascular complications in type 2 diabetic patients].
    Moleda P; Majkowska L; Safranow K; Adler G; Goracy I
    Przegl Lek; 2007; 64(3):134-9. PubMed ID: 17941464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.
    Stankovic AR; Fisher ND; Hollenberg NK
    J Am Soc Nephrol; 2006 Dec; 17(12):3293-9. PubMed ID: 17093063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
    Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
    Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
    Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
    J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE gene polymorphism and renal scarring in primary vesicoureteric reflux.
    Haszon I; Friedman AL; Papp F; Bereczki C; Baji S; Bodrogi T; Károly E; Endreffy E; Túri S
    Pediatr Nephrol; 2002 Dec; 17(12):1027-31. PubMed ID: 12478352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.